ELAN — Elanco Animal Health Incorporated Share News
0.000.00%
- $11.76bn
- $15.15bn
- $4.72bn
U.S. STOCKS ON THE MOVE-Aspen, Abercrombie & Fitch, Slide Insurance
U.S. STOCKS ON THE MOVE-Kohl's, J.M. Smucker, Prologis
U.S. STOCKS ON THE MOVE-Krispy Kreme, Canada Goose, Cracker Barrel
Elanco climbs on S&P MidCap inclusion
Elanco rises on S&P MidCap inclusion
Brief: Elanco Animal Health Set To Join S&P Midcap 400 Sarepta Therapeutics To Join S&P Smallcap 600
Brief: S&P Dow Jones Indices Elanco Animal Health Set To Join S&P Midcap 400 Sarepta Therapeutics To Join S&P Smallcap 600
U.S. STOCKS ON THE MOVE-Sempra, Occidental Petroleum, APA
Elanco Animal Health Inc reports results for the quarter ended June 30 - Earnings Summary
U.S. STOCKS ON THE MOVE-Papa John, Elanco, Paycom,
Elanco gains after revenue, profit forecast raise
Elanco Animal Health beats Q2 revenue estimates, raises FY guidance
Brief: Elanco Secures Approval Of Zenrelia(Ilunocitinib) In The European Union (EU)
Elanco's dog flu vaccine gets USDA nod
Brief: Elanco Receives USDA Nod For Trucan Ultra Civ Canine Flu Vaccine
Australia's Neurizon Therapeutics jumps on licensing agreement with Elanco
Brief: Elanco Animal Health Enters First Amendment To Receivables Loan Agreement - SEC Filing
Brief: Elanco Receives Positive Opinion On Zenrelia From EU's Committee
Brief: Elanco Appoints Robert Vanhimbergen As Chief Financial Officer